Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 546857

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience

Nagy, E.; Urbán, E.; Nord, C.E.; Piérard, D.; Glupczynski, Y.; Nonhoff, C.; Ieven, M.; Kalenić, Smilja; Chmelarova, E.; Könönen, E. et al.
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience // Clinical microbiology and infection, 17 (2011), 3; 371-379 doi:10.1111/j.1469-0691.2010.03256.x (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 546857 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience

Autori
Nagy, E. ; Urbán, E. ; Nord, C.E. ; Piérard, D. ; Glupczynski, Y. ; Nonhoff, C. ; Ieven, M. ; Kalenić, Smilja ; Chmelarova, E. ; Könönen, E. ; Calvet, L. ; Dubreuil, L. ; Dósa, E. ; Papaparaskevas, J. ; Szikra, L. ; Miszti, C. ; Terhes, G. ; Mazzariol, A. ; Vila, J. ; Hedberg, M. ; Degener, J. ; Wildeboer-Veloo, L. ; Gürler, N. ; Gürler, S. ; Ulger, N.

Izvornik
Clinical microbiology and infection (1198-743X) 17 (2011), 3; 371-379

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Antimicrobial; susceptibility; Bacteroides fragilis; Europe
(Antimicrobial susceptibility; Bacteroides fragilis; Europe)

Sažetak
Abstract The susceptibilities of 824 Bacteroides fragilis group isolates against nine antibiotics were evaluated in a Europe-wide study involving 13 countries. Species determination, by different methods, was carried out on all but one isolate. Resistance rates were evaluated according to species and geographical areas via CLSI and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints. The present data were compared with those obtained 10 and 20 years ago at a European level. High-level resistance (MIC ≥ 64 mg/L) to ampicillin was observed in 44.5% of the strains, which is a significant increase relative to 20 years ago (16%). Piperacillin/tazobactam was more active than amoxicillin/clavulanic acid (3.1% and 10.4% resistance, respectively), again with a resistance increase relative to earlier studies. Dramatic increases in resistance were observed for cefoxitin, clindamycin and moxifloxacin, with rates of 17.2%, 32.4% and 13.6%, respectively. The lowest resistances were found for imipenem, metronidazole and tigecycline (1.2%, <1% and 1.7%). Nonsusceptible strains to imipenem and metronidazole were more resistant to other anti-anaerobic drugs. Differences were detected between geographical areas, with higher resistance rates for moxifloxacin in Scandinavian countries (21.4%) than in Mediterranean countries (5.4%), whereas, for clindamycin, the resistance rates were higher in Mediterranean (41.8%) and lower in Scandinavian countries (22.5%). Piperacillin/tazobactam resistance was also higher in Scandinavian countries.

Izvorni jezik
Engleski



POVEZANOST RADA

Projekti:
108-1080114-0017 - Genotipovi i činitelji virulencije uzročnika bolničkih infekcija (Budimir, Ana, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Smilja Kalenić (autor)

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada doi onlinelibrary.wiley.com

Citiraj ovu publikaciju:

Nagy, E.; Urbán, E.; Nord, C.E.; Piérard, D.; Glupczynski, Y.; Nonhoff, C.; Ieven, M.; Kalenić, Smilja; Chmelarova, E.; Könönen, E. et al.
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience // Clinical microbiology and infection, 17 (2011), 3; 371-379 doi:10.1111/j.1469-0691.2010.03256.x (međunarodna recenzija, članak, znanstveni)
Nagy, E., Urbán, E., Nord, C., Piérard, D., Glupczynski, Y., Nonhoff, C., Ieven, M., Kalenić, S., Chmelarova, E. & Könönen, E. (2011) Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience. Clinical microbiology and infection, 17 (3), 371-379 doi:10.1111/j.1469-0691.2010.03256.x.
@article{article, author = {Nagy, E. and Urb\'{a}n, E. and Nord, C.E. and Pi\'{e}rard, D. and Glupczynski, Y. and Nonhoff, C. and Ieven, M. and Kaleni\'{c}, Smilja and Chmelarova, E. and K\"{o}n\"{o}nen, E. and Calvet, L. and Dubreuil, L. and D\'{o}sa, E. and Papaparaskevas, J. and Szikra, L. and Miszti, C. and Terhes, G. and Mazzariol, A. and Vila, J. and Hedberg, M. and Degener, J. and Wildeboer-Veloo, L. and G\"{u}rler, N. and G\"{u}rler, S. and Ulger, N.}, year = {2011}, pages = {371-379}, DOI = {10.1111/j.1469-0691.2010.03256.x}, keywords = {Antimicrobial, susceptibility, Bacteroides fragilis, Europe}, journal = {Clinical microbiology and infection}, doi = {10.1111/j.1469-0691.2010.03256.x}, volume = {17}, number = {3}, issn = {1198-743X}, title = {Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience}, keyword = {Antimicrobial, susceptibility, Bacteroides fragilis, Europe} }
@article{article, author = {Nagy, E. and Urb\'{a}n, E. and Nord, C.E. and Pi\'{e}rard, D. and Glupczynski, Y. and Nonhoff, C. and Ieven, M. and Kaleni\'{c}, Smilja and Chmelarova, E. and K\"{o}n\"{o}nen, E. and Calvet, L. and Dubreuil, L. and D\'{o}sa, E. and Papaparaskevas, J. and Szikra, L. and Miszti, C. and Terhes, G. and Mazzariol, A. and Vila, J. and Hedberg, M. and Degener, J. and Wildeboer-Veloo, L. and G\"{u}rler, N. and G\"{u}rler, S. and Ulger, N.}, year = {2011}, pages = {371-379}, DOI = {10.1111/j.1469-0691.2010.03256.x}, keywords = {Antimicrobial susceptibility, Bacteroides fragilis, Europe}, journal = {Clinical microbiology and infection}, doi = {10.1111/j.1469-0691.2010.03256.x}, volume = {17}, number = {3}, issn = {1198-743X}, title = {Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience}, keyword = {Antimicrobial susceptibility, Bacteroides fragilis, Europe} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.